BNP Paribas Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
3,662
+3,518
+2,443% +$361K ﹤0.01% 1338
2026
Q1
$15.7K Sell
144
-25
-15% -$2.38K ﹤0.01% 2094
2025
Q4
$14K Buy
169
+35
+26% +$3.01K ﹤0.01% 2053
2025
Q3
$12K Buy
134
+15
+13% +$1.34K ﹤0.01% 1570
2025
Q2
$10K Buy
+119
New +$9.95K ﹤0.01% 1772

Other funds holding LMAT

BNP Paribas Asset Management's LMAT Position: Q2 2026 in Review

BNP Paribas Asset Management increased its LeMaitre Vascular (LMAT) stake by 2,443% in Q2 2026, buying an estimated $361K and bringing the position to 3,662 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

BNP Paribas Asset Management first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • BNP Paribas Asset Management held 3,662 shares of LeMaitre Vascular worth $351K as of Q2 2026.
  • BNP Paribas Asset Management bought 3,518 LeMaitre Vascular shares in Q2 2026, an estimated $361K.
  • LeMaitre Vascular made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1338 holding.
  • BNP Paribas Asset Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.